After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...

CytoMed has generated the critical cell banks for the iPSC-derived hybrid of gamma delta T and Natural Killer cell technology and is currently undergoing process development into a potentially very ...

A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...

How a radical surgical approach saved the life of a neonatal nurse practitioner with a rare abdominal cancer - but meant ...

Yet, uptake levels of vaccines in the US would tell a different story. As of mid-December, only 20.9 percent of adults in the ...

Maersk on Thursday said it expects to grow its business to track an expected 4% growth in container shipping this year, even ...

Research has identified microRNAs as potential biomarkers for predicting COVID-19-related mortality in patients with cancer.

HOSPITALS in England have been hit by a surge of a “highly infectious” winter vomiting bug – and experts have warned you can ...

Nissan CEO Makoto Uchida met with Honda counterpart Toshihiro Mibe on Thursday to say he wanted to end their merger talks ...

Be it from tap water on a vacation, some dodgy chicken, or something the kids have brought home from school, we've almost all been flattened by an awful stomach bug at some point in our lives. For ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.